40
Alercell Inc raises $1.5M for biotech development in Montana
Company raise · Raising · BOZEMAN, US, MT · Form D filed 2026-10-19
Alercell Inc, a Montana-incorporated biotechnology company, is raising $1.5M under Regulation D exemption 6(b). The company has sold $35K to 3 investors so far and is accepting non-accredited investors with a $5K minimum.
Note: Company is new to EDGAR and has raised only $35K of $1.5M offering as of filing date; early-stage raise with non-accredited investors.
First raise on EDGARNon-accredited investorsoperating_company
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Frederic George-Etienne Scheer | Executive Officer |
Signed by Frederic Scheer, CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.